ReproNovo is a biopharmaceutical company developing innovative therapeutic solutions for reproductive medicine and women's health, including male and female infertility and uterine conditions like adenomyosis. Founded in 2021 and headquartered in Lausanne, Switzerland, the company has two Phase 2 clinical-stage assets: RPN-001 (leflutrozole) for male infertility and RPN-002 (nolasiban) for adenomyosis management and improved IVF outcomes.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountMay 2025
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
